Back to Authors

Advani, Ranjana

Mayo Clinic

From the Division of Hematology, Mayo Clinic, Rochester, MN (S.M.A.); the University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom (J.R.); BC Cancer Centre for Lymphoid Cancer, Va

Citations 1

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma

New England Journal of Medicine | July 13, 2022 | Volume: 387 | Issue: 4 | Pages: 310-320

10.1056/nejmoa2206125 | PMID 35830649